Your browser doesn't support javascript.
loading
Improvement of Huangqi Decoction on Endothelial Dysfunction in 5/6 Nephrectomized Rats.
Chu, Shuang; Wang, Li; Mao, Xiao-Dong; Peng, Wen.
Afiliação
  • Chu S; Laboratory of Renal Disease, Putuo Hospital, Shanghai University of Traditional Chinese Medicine, Shanghai, China.
Cell Physiol Biochem ; 40(6): 1354-1366, 2016.
Article em En | MEDLINE | ID: mdl-27997907
ABSTRACT
BACKGROUND/

AIMS:

Endothelial dysfunction is a major factor in the progression of chronic kidney disease, which correlates with oxidative stress and NO deficiency. Huangqi decoction (HQD) is a potential anti-oxidant ingredient in renoprotection. However, the underlying mechanisms remained identified. Therefore, we investigated whether HQD exhibit improvement in endothelial dysfunction in the 5/6 nephrectomy (Nx) rat model.

METHODS:

Male Wistar rats (180 - 250 g) were divided into sham, Nx and Nx + HQD (0.05, 0.15 and 0.45 g/kg) group, respectively. Renal function and histology were examined with ELISA and Immunohistochemical analysis. Endothelium-dependent relaxation of rat aortas was investigated by isometric tension recordings. Oxidative stress and NO bioavailability were detected by ELISA, DHE-staining, DAF-2 staining and western blotting.

RESULTS:

Compared with Nx rats, HQD treatment reversed the functional and structural changes of kidney significantly. Besides, endothelium-dependent relaxation of rat aortas was also improved by HQD treatment. NADPH oxidase and ROS generation were inhibited while NO bioavailability was enhanced.

CONCLUSION:

HQD can act as a potent prescription for the treatment of endothelium related vascular complications.
Assuntos

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Medicamentos de Ervas Chinesas / Endotélio Vascular / Nefrectomia Tipo de estudo: Prognostic_studies Limite: Animals Idioma: En Revista: Cell Physiol Biochem Assunto da revista: BIOQUIMICA / FARMACOLOGIA Ano de publicação: 2016 Tipo de documento: Article País de afiliação: China

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Medicamentos de Ervas Chinesas / Endotélio Vascular / Nefrectomia Tipo de estudo: Prognostic_studies Limite: Animals Idioma: En Revista: Cell Physiol Biochem Assunto da revista: BIOQUIMICA / FARMACOLOGIA Ano de publicação: 2016 Tipo de documento: Article País de afiliação: China